estriol has been researched along with Cancer of Endometrium in 10 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No one atypical endometrial hyperplasia and endometrial intraepithelial neoplasia case during the study period was found." | 3.11 | Genitourinary syndrome, local oestrogen therapy and endometrial pathology: a single-centre, randomised study. ( Kovachev, MS; Kovachev, SM, 2022) |
| " However, little is known about the risk of breast cancer and endometrial cancer after long-term use of different estrogen-progestin combinations." | 2.41 | [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. ( Magnusson, C; Weiderpass, E, 2001) |
| " In conclusion, 2ME, alone or in combination with TRAIL, may be an effective treatment for cancers of uterine origin with minimal toxicity to corresponding healthy female reproductive tissue." | 1.34 | The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. ( Brañes, J; Brosens, JJ; Cuello, M; Kato, S; Lange, S; Owen, GI; Sadarangani, A; Villalón, M, 2007) |
| "Mortality from endometrial cancer was not related to the prescription of weak estrogens or an estrogen-progestin combination, but mortality was 40% higher in women prescribed more potent estrogens without a progestin." | 1.30 | Cause-specific mortality in women receiving hormone replacement therapy. ( Adami, HO; Hoover, R; Persson, I; Schairer, C, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slomovitz, BM | 1 |
| Filiaci, VL | 1 |
| Walker, JL | 1 |
| Taub, MC | 1 |
| Finkelstein, KA | 1 |
| Moroney, JW | 1 |
| Fleury, AC | 1 |
| Muller, CY | 1 |
| Holman, LL | 1 |
| Copeland, LJ | 1 |
| Miller, DS | 1 |
| Coleman, RL | 1 |
| Kovachev, SM | 1 |
| Kovachev, MS | 1 |
| Davis, R | 1 |
| Batur, P | 1 |
| Thacker, HL | 1 |
| Stanosz, S | 1 |
| Mizunuma, H | 1 |
| Kato, S | 1 |
| Sadarangani, A | 1 |
| Lange, S | 1 |
| Villalón, M | 1 |
| Brañes, J | 1 |
| Brosens, JJ | 1 |
| Owen, GI | 1 |
| Cuello, M | 1 |
| Niwa, K | 1 |
| Murase, T | 1 |
| Furui, T | 1 |
| Morishita, S | 1 |
| Mori, H | 2 |
| Tanaka, T | 1 |
| Tamaya, T | 1 |
| Schairer, C | 1 |
| Adami, HO | 2 |
| Hoover, R | 1 |
| Persson, I | 2 |
| Weiderpass, E | 2 |
| Baron, JA | 1 |
| Magnusson, C | 2 |
| Lindgren, A | 1 |
| Bergström, R | 1 |
| Correia, N | 1 |
3 reviews available for estriol and Cancer of Endometrium
| Article | Year |
|---|---|
Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
Topics: Aged; Biosimilar Pharmaceuticals; Drug Compounding; Endometrial Neoplasms; Estradiol; Estriol; Estro | 2014 |
[Treatment of osteoporosis with estrogen].
Topics: Bone Density; Breast Neoplasms; Endometrial Neoplasms; Estriol; Estrogen Replacement Therapy; Estrog | 2004 |
[Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Topics: Aged; Breast Neoplasms; Case-Control Studies; Climacteric; Endometrial Neoplasms; Estriol; Estrogen | 2001 |
2 trials available for estriol and Cancer of Endometrium
| Article | Year |
|---|---|
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometrial Neoplasms; Estradiol; | 2022 |
Genitourinary syndrome, local oestrogen therapy and endometrial pathology: a single-centre, randomised study.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estriol; Estrogen Replacement Therapy; | 2022 |
5 other studies available for estriol and Cancer of Endometrium
| Article | Year |
|---|---|
An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women.
Topics: Adult; Bromocriptine; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Estriol; Female; | 2009 |
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium.
Topics: 17-Hydroxysteroid Dehydrogenases; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cell Line, | 2007 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
Cause-specific mortality in women receiving hormone replacement therapy.
Topics: Adult; Aged; Cause of Death; Cerebrovascular Disorders; Cohort Studies; Confidence Intervals; Drug T | 1997 |
Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Topics: Administration, Intravaginal; Administration, Oral; Aged; Case-Control Studies; Endometrial Hyperpla | 1999 |